BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 32532027)

  • 1. Lysophosphatidic Acid Receptor 5 Plays a Pathogenic Role in Brain Damage after Focal Cerebral Ischemia by Modulating Neuroinflammatory Responses.
    Sapkota A; Lee CH; Park SJ; Choi JW
    Cells; 2020 Jun; 9(6):. PubMed ID: 32532027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lysophosphatidic acid receptor 1 (LPA
    Gaire BP; Sapkota A; Song MR; Choi JW
    J Neuroinflammation; 2019 Aug; 16(1):170. PubMed ID: 31429777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lysophosphatidic Acid Receptor 5 Contributes to Imiquimod-Induced Psoriasis-Like Lesions through NLRP3 Inflammasome Activation in Macrophages.
    Gaire BP; Lee CH; Kim W; Sapkota A; Lee DY; Choi JW
    Cells; 2020 Jul; 9(8):. PubMed ID: 32707926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sphingosine 1-phosphate receptor subtype 3 (S1P
    Gaire BP; Song MR; Choi JW
    J Neuroinflammation; 2018 Oct; 15(1):284. PubMed ID: 30305119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Receptor for Advanced Glycation End Products Is Involved in LPA
    Sapkota A; Park SJ; Choi JW
    Life (Basel); 2021 Jan; 11(2):. PubMed ID: 33499230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of Sphingosine 1-Phosphate Receptor Subtype 1 (S1P
    Gaire BP; Lee CH; Sapkota A; Lee SY; Chun J; Cho HJ; Nam TG; Choi JW
    Mol Neurobiol; 2018 Mar; 55(3):2320-2332. PubMed ID: 28343295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. S1P
    Sapkota A; Gaire BP; Kang MG; Choi JW
    Sci Rep; 2019 Aug; 9(1):12106. PubMed ID: 31431671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NLRP3 Inflammasome Activation Is Involved in LPA
    Lee CH; Sapkota A; Gaire BP; Choi JW
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33202644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eupatilin exerts neuroprotective effects in mice with transient focal cerebral ischemia by reducing microglial activation.
    Sapkota A; Gaire BP; Cho KS; Jeon SJ; Kwon OW; Jang DS; Kim SY; Ryu JH; Choi JW
    PLoS One; 2017; 12(2):e0171479. PubMed ID: 28178289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of LPA
    Sapkota A; Park SJ; Choi JW
    Biomol Ther (Seoul); 2020 Nov; 28(6):512-518. PubMed ID: 33024060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identifying lysophosphatidic acid receptor subtype 1 (LPA
    Kwon JH; Gaire BP; Park SJ; Shin DY; Choi JW
    Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Oct; 1863(10):1237-1245. PubMed ID: 30071304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroprotective effect of 6-paradol in focal cerebral ischemia involves the attenuation of neuroinflammatory responses in activated microglia.
    Gaire BP; Kwon OW; Park SH; Chun KH; Kim SY; Shin DY; Choi JW
    PLoS One; 2015; 10(3):e0120203. PubMed ID: 25789481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lysophosphatidic Acid Receptor 5 (LPA
    Joshi L; Plastira I; Bernhart E; Reicher H; Koshenov Z; Graier WF; Vujic N; Kratky D; Rivera R; Chun J; Sattler W
    Cells; 2022 Mar; 11(7):. PubMed ID: 35406635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lysophosphatidic Acid Receptor 1 Plays a Pathogenic Role in Permanent Brain Ischemic Stroke by Modulating Neuroinflammatory Responses.
    Tiwari S; Basnet N; Choi JW
    Biomol Ther (Seoul); 2024 May; 32(3):319-328. PubMed ID: 38627097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Matrix Metalloproteinase-8 is a Novel Pathogenetic Factor in Focal Cerebral Ischemia.
    Han JE; Lee EJ; Moon E; Ryu JH; Choi JW; Kim HS
    Mol Neurobiol; 2016 Jan; 53(1):231-239. PubMed ID: 25421209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of Flower Buds Extract of Tussilago farfara on Focal Cerebral Ischemia in Rats and Inflammatory Response in BV2 Microglia.
    Hwang JH; Kumar VR; Kang SY; Jung HW; Park YK
    Chin J Integr Med; 2018 Nov; 24(11):844-852. PubMed ID: 30090976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analgesic effects of novel lysophosphatidic acid receptor 5 antagonist AS2717638 in rodents.
    Murai N; Hiyama H; Kiso T; Sekizawa T; Watabiki T; Oka H; Aoki T
    Neuropharmacology; 2017 Nov; 126():97-107. PubMed ID: 28859883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The protective role of proton-sensing TDAG8 in the brain injury in a mouse ischemia reperfusion model.
    Sato K; Tobo A; Mogi C; Tobo M; Yamane N; Tosaka M; Tomura H; Im DS; Okajima F
    Sci Rep; 2020 Oct; 10(1):17193. PubMed ID: 33057165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of lysophosphatidic acid receptor 5 on NLRC4 inflammasome in brain tissues of transient cerebral ischemia/reperfusion rat.
    Zhang X; Huang T; Lang L; Yu L
    Hum Exp Toxicol; 2022; 41():9603271221078870. PubMed ID: 35230166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of NF-κB activation is associated with anti-inflammatory and anti-apoptotic effects of Ginkgolide B in a mouse model of cerebral ischemia/reperfusion injury.
    Gu JH; Ge JB; Li M; Wu F; Zhang W; Qin ZH
    Eur J Pharm Sci; 2012 Nov; 47(4):652-60. PubMed ID: 22850444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.